A Platform Study of Novel Agents in Combination With Radiotherapy in NSCLC
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Durvalumab
Related studies linked through entity extraction aliases.
Radiation and Durvalumab Immunotherapy As Neoadjuvant Treatment for MIBC
- Status
- UNKNOWN
- Phase
- PHASE2
A Phase 1b/2 Study of T-DXd Combinations in HER2-positive Metastatic Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Olaparib (LYNPARZA) Plus Durvalumab (IMFINZI) in EGFR-Mutated Adenocarcinomas That Transform to Small Cell Lung Cancer (SCLC) and Other Neuroendocrine Tumors
- Status
- TERMINATED
- Phase
- PHASE2
Durvalumab and Tremelimumab in Combination With Y-90 SIRT for Intermediate Stage HCC
- Status
- RECRUITING
- Phase
- PHASE2
Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
The Combination Therapy of TACE and Ablation With Durvalumab in Hepatocellular Carcinoma at Intermediate Stage (TAD)
- Status
- NOT_YET_RECRUITING
- Phase
- NA
A Study of Atezolizumab and Tiragolumab Compared With Durvalumab in Participants With Locally Advanced, Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE3
First Time in Human Study of AZD8701 With or Without Durvalumab in Participants With Advanced Solid Tumours
- Status
- COMPLETED
- Phase
- PHASE1
Durvalumab and Tremelimumab in Combination With Chemotherapy in HIV-infected Patients With Non-small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study of AZD4635 With Durvalumab and With Cabazitaxel and Durvalumab in Patients With mCRPC.
- Status
- COMPLETED
- Phase
- PHASE2
Thoracic Radiotherapy Plus Maintenance Durvalumab After First Line Carboplatin and Etoposide Plus Durvalumab in Extensive-stage Disease Small Cell Lung Cancer (ED-SCLC).
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Durvalumab or Durvalumab Plus Chemotherapy in Kras Mutation Positive and PD-L1 High (≥ 50%) NSCLC Patients
- Status
- WITHDRAWN
- Phase
- PHASE2
Efficacy and Safety of CRT, Durvalumab and Surgery for SST
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Acalabrutinib and Durvalumab in Primary and Secondary Central Nervous System Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Concurrent Chemoradiation and Durvalumab for Locoregionally Advanced Nasopharyngeal Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Durvalumab and Lenvatinib in Participants With Advanced and Recurrent Endometrial Carcinoma
- Status
- UNKNOWN
- Phase
- NA
Chemoradiation Followed by Durvalumab in Poor Risk and/or Elderly Patients With Stage III NSCLC
- Status
- TERMINATED
- Phase
- PHASE2
Durvalumab With/Without Tremelimumab After Palliative Hypofractionated Radiotherapy for Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Study to Access Safety of Durvalumab in Indian Adult Patients With Locally Advanced NSCLC
- Status
- COMPLETED
- Phase
- PHASE4